PRLD

#2844
Prelude Therapeutics Incorporated - Common Stock
3.9 2 USD
-0.25%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.92
3.92
Year Range
0.77
5.54
Daily Change
-0.25%
Monthly Change
-13.08%
6 month change
+134.73%
Year Change
+340.45%
Previous Close
3.9 3
Open
3.9 2
Low
3.9 2
High
3.9 2
Volume
16
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 312.21 M
  • Employee 79
  • Founded 2016
  • CEO N/A
  • Website www.preludetx.com
  • Headquarter Delaware, United States
  • FIGI BBG00K7JY2Q6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.25
Price to sales ratio
18.38

News